Once licensed and in the market DEP SN38 can potentially generate billions of dollars in revenue based on what is out there to treat multiple cancers
Hopefully after waiting for the regulators to finalise their protocols Starpharma can make public it's partner/s
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
-0.005(4.76%) |
Mkt cap ! $41.82M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.5¢ | 10.0¢ | $41.09K | 399.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 359599 | 9.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 209650 | 2 |
View Market Depth
| Last trade - 16.10pm 08/08/2025 (20 minute delay) ? |
| SPL (ASX) Chart |